Pash: Stromal and Pseudoangiomatous
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
35 Cyproterone Acetate and Ethinyl Estradiol Tablets 2 Mg/0
PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PrCYESTRA®-35 cyproterone acetate and ethinyl estradiol tablets 2 mg/0.035 mg THERAPEUTIC CLASSIFICATION Acne Therapy Paladin Labs Inc. Date of Preparation: 100 Alexis Nihon Blvd, Suite 600 January 17, 2019 St-Laurent, Quebec H4M 2P2 Version: 6.0 Control # 223341 _____________________________________________________________________________________________ CYESTRA-35 Product Monograph Page 1 of 48 Table of Contents PART I: HEALTH PROFESSIONAL INFORMATION ....................................................................... 3 SUMMARY PRODUCT INFORMATION ............................................................................................. 3 INDICATION AND CLINICAL USE ..................................................................................................... 3 CONTRAINDICATIONS ........................................................................................................................ 3 WARNINGS AND PRECAUTIONS ....................................................................................................... 4 ADVERSE REACTIONS ....................................................................................................................... 13 DRUG INTERACTIONS ....................................................................................................................... 16 DOSAGE AND ADMINISTRATION ................................................................................................ 20 OVERDOSAGE .................................................................................................................................... -
Surgical Approach to the Treatment of Gynecomastia According to Its Classification
ARTIGO ORIGINAL Abordagem cirúrgica para o tratamentoVendraminFranco da T ginecomastia FSet al.et al. conforme sua classificação Abordagem cirúrgica para o tratamento da ginecomastia conforme sua classificação Surgical approach to the treatment of gynecomastia according to its classification MÁRIO MÚCIO MAIA DE RESUMO MEDEIROS1 Introdução: A ginecomastia é a proliferação benigna mais comum do tecido glandular da mama masculina, causada pela alteração do equilíbrio entre as concentrações de estrógeno e andrógeno. Na maioria dos casos, o principal tratamento é a cirurgia. O objetivo deste tra- balho foi demonstrar a aplicabilidade das técnicas cirúrgicas consagradas para a correção da ginecomastia, de acordo com a classificação de Simon, e apresentar uma nova contribuição. Método: Este trabalho foi realizado no período de março de 2009 a março de 2011, sendo incluídos 32 pacientes do sexo masculino, com idades entre 13 anos e 45 anos. A escolha da incisão foi relacionada à necessidade ou não de ressecção de pele. Foram utilizadas quatro técnicas da literatura e uma modificação da técnica por incisão circular com prolongamentos inferior, superior, lateral e medial, quando havia excesso de pele também no polo inferior da mama. Resultados: A principal causa da ginecomastia identificada entre os pacientes foi idiopática, seguida pela obesidade e pelo uso de esteroides anabolizantes. Conclusões: A técnica mais utilizada foi a incisão periareolar inferior proposta por Webster, quando não houve necessidade de ressecção de pele. Na presença de excesso de pele, a técnica escolhi- da variou de acordo com a quantidade do tecido a ser ressecado. A nova técnica proposta permitiu maior remoção do tecido dermocutâneo glandular e gorduroso da mama, quando comparada às demais técnicas utilizadas na experiência do cirurgião. -
Clinical and Imaging Evaluation of Nipple Discharge
REVIEW ARTICLE Evaluation of Nipple Discharge Clinical and Imaging Evaluation of Nipple Discharge Yi-Hong Chou, Chui-Mei Tiu*, Chii-Ming Chen1 Nipple discharge, the spontaneous release of fluid from the nipple, is a common presenting finding that may be caused by an underlying intraductal or juxtaductal pathology, hormonal imbalance, or a physiologic event. Spontaneous nipple discharge must be regarded as abnormal, although the cause is usually benign in most cases. Clinical evaluation based on careful history taking and physical examination, and observation of the macroscopic appearance of the discharge can help to determine if the discharge is physiologic or pathologic. Pathologic discharge can frequently be uni-orificial, localized to a single duct and to a unilateral breast. Careful assessment of the discharge is mandatory, including testing for occult blood and cytologic study for malignant cells. If the discharge is physiologic, reassurance of its benign nature should be given. When a pathologic discharge is suspected, the main goal is to exclude the possibility of carcinoma, which accounts for only a small proportion of cases with nipple discharge. If the woman has unilateral nipple discharge, ultrasound and mammography are frequently the first investigative steps. Cytology of the discharge is routine. Ultrasound is particularly useful for localizing the dilated duct, the possible intraductal or juxtaductal pathology, and for guidance of aspiration, biopsy, or preoperative wire localization. Galactography and magnetic resonance imaging can be selectively used in patients with problematic ultrasound and mammography results. Whenever there is an imaging-detected nodule or focal pathology in the duct or breast stroma, needle aspiration cytology, core needle biopsy, or excisional biopsy should be performed for diagnosis. -
Olanzapine-Induced Hyperprolactinemia: Two Case Reports
CASE REPORT published: 29 July 2019 doi: 10.3389/fphar.2019.00846 Olanzapine-Induced Hyperprolactinemia: Two Case Reports Pedro Cabral Barata *, Mário João Santos, João Carlos Melo and Teresa Maia Departamento de Psiquiatria, Hospital Prof. Dr. Fernando da Fonseca, EPE, Amadora, Portugal Background: Hyperprolactinemia is a common consequence of treatment with antipsychotics. It is usually defined by a sustained prolactin level above the laboratory upper level of normal in conditions other than that where physiologic hyperprolactinemia is expected. Normal prolactin levels vary significantly among different laboratories and studies. Several studies indicate that olanzapine does not significantly affect serum prolactin levels in the long term, although this statement has been challenged. Aims: Our aim is to report two olanzapine-induced hyperprolactinemia cases observed in psychiatric consultations. Methods: Medical records of the patients who developed this clinical situation observed Edited by: in psychiatric consultations in the Psychiatry Department of the Prof. Dr. Fernando Angel L. Montejo, Fonseca Hospital during the year of 2017 were analyzed, complemented with a non- University of Salamanca, Spain systematic review of the literature. Reviewed by: Carlos Spuch, Results: The case reports consider two women who developed prolactin-related Instituto de Investigación Sanitaria symptoms after the initiation of olanzapine. No baseline prolactinemia was obtained, and Galicia Sur (IISGS), Spain Lucio Tremolizzo, prolactin serum levels were only evaluated after prolactin-related symptoms developed: University of Milano-Bicocca, Italy at the time of its measurement, both patients had been taking olanzapine for more *Correspondence: than 24 weeks. Hyperprolactinemia was found to be present in Case 2, whereas Case Pedro Cabral Barata 1 (a 49-year-old woman) had “normal” serum prolactin levels for premenopausal and [email protected] prolactin levels slightly above the maximum levels for postmenopausal women. -
Breast Infection: a Review of Diagnosis and Management Practices
Review Eur J Breast Health 2018; 14: 136-143 DOI: 10.5152/ejbh.2018.3871 Breast Infection: A Review of Diagnosis and Management Practices Eve Boakes1 , Amy Woods2 , Natalie Johnson1 , Naim Kadoglou1 1Department of General Surgery, London North West Healthcare NHS Trust, Northwick Park Hospital, Middlesex, Londan 2Department of Medicine, Croydon University Hospital, Croydon, London ABSTRACT Mastitis is a common condition that predominates during the puerperium. Breast abscesses are less common, however when they do develop, delays in specialist referral may occur due to lack of clear protocols. In secondary care abscesses can be diagnosed by ultrasound scan and in the past the management has been dependent on the receiving surgeon. Management options include aspiration under local anesthetic or more invasive incision and drainage (I&D). Over recent years the availability of bedside/clinic based ultrasound scan has made diagnosis easier and minimally invasive procedures have become the cornerstone of breast abscess management. We review the diagnosis and management of breast infection in the primary and secondary care setting, highlighting the importance of early referral for severe infection/breast abscesses. As a clear guideline on the manage- ment of breast infection is lacking, this review provides useful guidance for those who rarely see breast infection to help avoid long-term morbidity. Keywords: Mastitis, abscess, infection, lactation Cite this article as: Boakes E, Woods A, Johnson N, Kadoglou. Breast Infection: A Review of Diagnosis and Management Practices. Eur J Breast Health 2018; 14: 136-143. Introduction Mastitis is a relatively common breast condition; it can affect patients at any time but predominates in women during the breast-feeding period (1). -
Benign Breast Diseases1
BENIGN BREAST DISEASES PROFFESOR.S.FLORET NORMAL STRUCTURE DEVELOPMENTAL/CONGENITAL • Polythelia • Polymastia • Athelia • Amastia ‐ poland syndrome • Nipple inversion • Nipple retraction • NON‐BREAST DISORDERS • Tietze disease • Sebaceous cyst & other skin disorders. • Monder’s disease BENIGN DISEASE OF BREAST • Fibroadenoma • Fibroadenosis‐ ANDI • Duct ectasia • Periductal papilloma • Infective conditions‐ Mastitis ‐ Breast abscess ‐ Antibioma ‐ Retromammary abscess Trauma –fat necrosis. NIPPLE INVERSION • Congenital abnormality • 20% of women • Bilateral • Creates problem during breast feeding • Cosmetic surgery does not yield normal protuberant nipple. NIPPLE INVERSION NIPPLE RETRACTION • Nipple retraction is a secondary phenomenon due to • Duct ectasia‐ bilateral nipple retarction. • Past surgery • Carcinoma‐ short history,unilateral,palpable mass. NIPPLE RETRACTION ABERRATIONS OF NORMAL DEVELOPMENT AND INVOLUTION (ANDI) • Breast : Physiological dynamic structure. ‐ changes seen throught the life. • They are ‐ developmental & involutional ‐ cyclical & associated with pregnancy and lactation. • The above changes are described under ANDI. PATHOLOGY • The five basic pathological features are: • Cyst formation • Adenosis:increase in glandular issue • Fibrosis • Epitheliosis:proliferation of epithelium lining the ducts & acini. • Papillomatosis:formation of papillomas due to extensive epithelial hyperplasia. ANDI & CARCINOMA • NO RISK: • Mild hyperplasia • Duct ectasia. • SLIGHT INCREASED RISK(1.5‐2TIMES): • Moderate hyperplasia • Papilloma -
Common Breast Problems BROOKE SALZMAN, MD; STEPHENIE FLEEGLE, MD; and AMBER S
Common Breast Problems BROOKE SALZMAN, MD; STEPHENIE FLEEGLE, MD; and AMBER S. TULLY, MD Thomas Jefferson University Hospital, Philadelphia, Pennsylvania A palpable mass, mastalgia, and nipple discharge are common breast symptoms for which patients seek medical atten- tion. Patients should be evaluated initially with a detailed clinical history and physical examination. Most women pre- senting with a breast mass will require imaging and further workup to exclude cancer. Diagnostic mammography is usually the imaging study of choice, but ultrasonography is more sensitive in women younger than 30 years. Any sus- picious mass that is detected on physical examination, mammography, or ultrasonography should be biopsied. Biopsy options include fine-needle aspiration, core needle biopsy, and excisional biopsy. Mastalgia is usually not an indica- tion of underlying malignancy. Oral contraceptives, hormone therapy, psychotropic drugs, and some cardiovascular agents have been associated with mastalgia. Focal breast pain should be evaluated with diagnostic imaging. Targeted ultrasonography can be used alone to evaluate focal breast pain in women younger than 30 years, and as an adjunct to mammography in women 30 years and older. Treatment options include acetaminophen and nonsteroidal anti- inflammatory drugs. The first step in the diagnostic workup for patients with nipple discharge is classification of the discharge as pathologic or physiologic. Nipple discharge is classified as pathologic if it is spontaneous, bloody, unilat- eral, or associated with a breast mass. Patients with pathologic discharge should be referred to a surgeon. Galactorrhea is the most common cause of physiologic discharge not associated with pregnancy or lactation. Prolactin and thyroid- stimulating hormone levels should be checked in patients with galactorrhea. -
Breastfeeding After Breast Surgery-V3-Formatted
Breastfeeding After Breast and Nipple Surgeries: A Guide for Healthcare Professionals By Diana West, BA, IBCLC, RLC PURPOSE A satisfying breastfeeding relationship is not precluded by insufficient milk production. When measures are taken to protect the milk supply that exists, minimize supplementation, The purpose of this guide is to provide the healthcare and increase milk production when possible, a mother with professional with an understanding of breast and nipple compromised milk production can have a satisfying surgeries and their effects upon lactation and the breastfeeding relationship with her baby. breastfeeding relationship. The effect of breast and nipple surgery upon lactation functionality and breastfeeding dynamics varies according to the type of surgery performed. This guide has delineated discussion of breastfeeding after PREDICTING LACTATION breast and nipple surgeries according to the three broad CAPABILITY AFTER BREAST AND categories: diagnostic, ablative, and therapeutic breast procedures, cosmetic breast surgeries, and nipple surgeries. NIPPLE SURGERIES The reasons, motivations, issues, concerns, stresses, and physical and psychological results share some The aspect of breast and nipple surgeries that is most likely to commonalities, but are largely unique to the type of surgery affect lactation is the surgical treatment of the areola and performed. For this reason, each type of surgery and its nipple. The location, orientation, and length of the incision effect upon lactation will be discussed independently. directly affect lactation capability by severing the parenchyma Methods to assess milk production and an overview of and innervation to the nipple/areolar complex. An incision feeding options to maximize milk production when near or on the areola, particularly in the lower, outer quadrant supplementation is necessary are presented. -
Breast Uplift (Mastopexy) Procedure Aim and Information
Breast Uplift (Mastopexy) Procedure Aim and Information Mastopexy (Breast Uplift) The breast is made up of fat and glandular tissue covered with skin. Breasts may change with variable influences from hormones, weight change, pregnancy, and gravitational effects on the breast tissue. Firm breasts often have more glandular tissue and a tighter skin envelope. Breasts become softer with age because the glandular tissue gradually makes way for fatty tissue and the skin also becomes less firm. Age, gravity, weight loss and pregnancy may also influence the shape of the breasts causing ptosis (sagging). Sagging often involves loss of tissue in the upper part of the breasts, loss of the round shape of the breast to a more tubular shape and a downward migration of the nipple and areola (dark area around the nipple). A mastopexy (breast uplift) may be performed to correct sagging changes in the breast by any one or all of the following methods: 1. Elevating the nipple and areola 2. Increasing projection of the breast 3. Creating a more pleasing shape to the breast Mastopexy is an elective surgical operation and it typifies the trade-offs involved in plastic surgery. The breast is nearly always improved in shape, but at the cost of scars on the breast itself. A number of different types of breast uplift operations are available to correct various degrees of sagginess. Small degrees of sagginess can be corrected with a breast enlargement (augmentation) only if an increase in breast size is desirable, or with a scar just around the nipple with or without augmentation. -
Phd Thesis Summary
University of Medicine and Pharmacy of Craiova DOCTORAL SCHOOL PhD Thesis BREAST RECONSTRUCTION AFTER SURGERY FOR BREAST HIPERTROPHY AND BENIGN TUMORS Summary Ph.D. SUPERVISOR: Prof. univ. dr. Mihai Brăila Ph.D. CANDIDATE: Radu Claudiu Gabriel CRAIOVA 2013 INTRODUCTION According to statistics, only in the United States in 2012 over 14 million cosmetic surgery of the breasts were made, but only about 3% of these were for surgical breast reconstruction after mastectomy as an interventional oncology treatment, although about 300,000 women are diagnosed each year with mammary tumors and most of them suffer breast surgery that can vary from partial, segmental or total removal of the breast. This creates a major gap between the number of surgeons able to successfully carry out such intervention and the number of patients who would require them, making obvious the need to increase the number of professionals that are able to perform breast reconstruction after mastectomy, especially the aesthetic mastectomy in people diagnosed with breast hypertrophy. Based on medical literature data, in this study we aimed to elucidate, using specific research methods, the impact of clinical and psychological intervention of breast reconstruction in patients suffering from breast hypertrophy and benign tumors. We hope that our study will shade some light on the need of brest reconstruction, its impact on specific pathology (mammary hypertrophy and benign tumors) and to contribut in improving breast reconstruction techniques that can help to avoid any complication that may arise. CHAPTER I Functional anatomy of the mammary gland Adult female mammary gland is located on both side of the anterior chest having it's base stretching from about the second to the sixth rib. -
CASE REPORT Severe Gynaecomastia Associated with Highly Active Antiretroviral Therapy Faith C
Open Access CASE REPORT Severe gynaecomastia associated with highly active antiretroviral therapy Faith C. Muchemwa1,2, Clarice T. Madziyire2 1. Department of Surgery, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe 2. Department of Immunology, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe Correspondence: Dr Faith C. Muchemwa ([email protected]) © 2018 F.C. Muchemwa & C.T. Madziyire. This open access article is licensed under a Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), East Cent Afr J Surg. 2018 Aug;23(2):80–82 which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. https://dx.doi.org/10.4314/ecajs.v23i2.6 Abstract The association between gynaecomastia and HIV infection was first reported in 1987; however, there were no subsequent pub- lished reports of gynaecomastia linked to HIV infection until highly active antiretroviral therapy (HAART) was introduced. Although HAART significantly improves the prognosis of HIV infection, its extensive use has resulted in multiple adverse effects, including benign breast enlargement. We present a rare case of severe gynaecomastia in a male patient with vertically transmitted HIV on HAART. He was surgically treated with mastectomy with no nipple-areolar complex reconstruction. The pathology report con- firmed the benign nature of the breast tissue. Surgical intervention resulted in an improvement of daily activities and enhanced psychosocial wellbeing. Benign bilateral breast enlargement of this magnitude in a male patient has never been reported. -
1 Evidence Tables for Mastitis, Abscess and Related Conditions And
Evidence tables for mastitis, abscess and related conditions and issues Tabulation of studies on mastitis illustrates the heterogeneity of study design, definition of mastitis, and factors investigated. Recent studies on mastitis in Western populations have been included, with some older studies of particular interest. List of tables: Table A: Incidence and treatment of Mastitis Table B: Reviews of the literature Table B1: Core Reviews Table B2: Other review sources Table B3: Further reviews Table C: Women’s experience of mastitis Tables D: Abscess Table D1: Incidence of abscess Table D2: Interventions for abscess Table E: Overabundant milk supply Table F: Chronic breast pain Table G: Mastitis and breast augmentation Table H: Alternative treatments for mastitis Table I: Physiology of mastitis during lactation Table J: Role of specific pathogens Table J1: Role of Staphylococcus aureus in mastitis Table J2: Mastitis and MRSA Table J3: MRSA mastitis and abscess case study Table J4: Role of Corynebacterium Table K: Effects on the baby Table K1: Effects of mastitis on the baby Table K2: Antibiotic treatment of women during lactation – effects on the infant Table K3: Maternal Strep B infections and effects on the baby through breastfeeding. Table L: Prevention 1 Table A: Incidence and treatment of Mastitis: Factors associated with incidence (possible risk factors); also studies of treatment experienced by women with mastitis: Author Type of Definition of Outcomes measured Results Comments date study mastitis Scott 2008 Prospective Red, tender, hot, Incidence of mastitis, 18% (95% CI 14%, 21%) had at least one 72% of women longitudinal swollen area of the reoccurrence, timing of episode of mastitis invited to take UK cohort study breast accompanied by episodes.